Literature DB >> 21419282

Vitamin D as a T-cell modulator in multiple sclerosis.

Joost Smolders1, Jan Damoiseaux.   

Abstract

Vitamin D is a potent immune modulator, keeping the T-cell compartment in a more tolerogenic state. Multiple sclerosis (MS), a disease in which an autoreactive T-cell response contributes to inflammation in the central nervous system, has been associated with vitamin D deficiency. The effects of vitamin D on the immune system are believed to be an important driver of this association. In this chapter, we elaborate on vitamin D as a modulator of the T-cell response. This discussion will be placed in the perspective of MS as a T-cell-mediated disease and in the perspective of the numerous association studies on vitamin D deficiency and multiple health outcomes. We conclude that there is a firm experimental and epidemiological basis supporting the model of vitamin D as a physiological immune modulator, on which intervention studies assessing clinical and immunological outcome measures should be designed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419282     DOI: 10.1016/B978-0-12-386960-9.00018-6

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  15 in total

Review 1.  Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected].

Authors:  Bernadette Kalman; Erzsebet Toldy
Journal:  Neuromolecular Med       Date:  2014-04-08       Impact factor: 3.843

2.  Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Authors:  Egil Røsjø; Linn H Steffensen; Lone Jørgensen; Jonas C Lindstrøm; Jūratė Šaltytė Benth; Annika E Michelsen; Pål Aukrust; Thor Ueland; Margitta T Kampman; Øivind Torkildsen; Trygve Holmøy
Journal:  J Neurol       Date:  2015-10-01       Impact factor: 4.849

3.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

4.  Testing in mice the hypothesis that melanin is protective in malaria infections.

Authors:  Michael Waisberg; Brandi K Vickers; Stephanie B Yager; Christina K Lin; Susan K Pierce
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

Review 5.  Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.

Authors:  Colleen Elizabeth Hayes; Shane L Hubler; Jerott R Moore; Lauren E Barta; Corinne E Praska; Faye E Nashold
Journal:  Front Immunol       Date:  2015-03-18       Impact factor: 7.561

Review 6.  Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.

Authors:  Ming Lu; Bruce V Taylor; Heinrich Körner
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

7.  The Engagement Between Vitamin D and the Immune System: Is Consolidation by a Marriage to Be Expected?

Authors:  Jan Damoiseaux; Joost Smolders
Journal:  EBioMedicine       Date:  2018-04-18       Impact factor: 8.143

Review 8.  An Update on Vitamin D and Disease Activity in Multiple Sclerosis.

Authors:  Joost Smolders; Øivind Torkildsen; William Camu; Trygve Holmøy
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

9.  The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells.

Authors:  Zoë Urry; Emma S Chambers; Emmanuel Xystrakis; Sarah Dimeloe; David F Richards; Leona Gabryšová; Jillian Christensen; Atul Gupta; Sejal Saglani; Andrew Bush; Anne O'Garra; Zarin Brown; Catherine M Hawrylowicz
Journal:  Eur J Immunol       Date:  2012-08-20       Impact factor: 5.532

10.  Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.

Authors:  Barbara M van Amerongen; François Feron
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.